gvtcx

Provision of Analysers and Consumables to Test Total Protein Assays from Apheresis Donors and Donations

NHS Blood and Transplant Published 6 Feb 2026 Find a Tender

key details

Value£1,260,000 (£1,512,000 inc. VAT)
Statusplanning
Category (CPV) 38434000
OCIDocds-h6vhtk-064996

description

NHS Blood and Transplant (NHSBT) are responsible for collecting plasma and platelet donations in England. There is a requirement for NHSBT to undertake total protein testing on these donations and the donors.

As part of the preliminary market engagement exercise, NHSBT are seeking to engage with potential suppliers of analysers that can run total protein assays.

  1. General Requirements – Background:

For Donor Safety:

All apheresis donors require a total protein test on their first donation, and this is repeated at every 8th donation and at least annually. Total protein must not be less than 60g/L.

For Quality Monitoring:

Total protein is tested in:

  • a.1% of recovered plasma donations (from whole blood donations);
  • b.1% of apheresis plasma donations; and
  • c.1% of concurrent apheresis plasma donations (obtained during platelet donation).

Total protein must not be less than 50g/L.

NHSBT currently outsource this testing to a 3rd Party. NHSBT are considering bringing this testing in house from 2027. Please note a final decision has not been made on this and the information obtained from this preliminary market engagement will help to inform the decision.

  1. Requirement:

NHSBT potentially has a requirement for the purchase/loan of up to three analysers that can run special protein assays. Whilst total protein testing is the primary requirement, NHSBT may also be looking to test for immunoglobulins (IgG) and albumin as part of the requirement. As a general overview, the contracted supplier would be responsible for:

  • a.Providing analysers that can test for total protein, and ideally, also IgG and Albumin. This includes delivery of the machines to one/all of the three manufacturing sites – located at Filton, Colindale and Manchester;
  • b.Providing key consumables including assay-specific reagents;
  • c.Potentially providing the software (including training) to analyse the results – note: this requirement is still under consideration; and
  • d.Providing a maintenance and repair service to cover all planned maintenance and any repairs.
  • 3.Contract Duration:

The contract duration is still under consideration. The market engagement will enquire about machine lifespan which will further inform the contract length. The current assumption is 5 years plus 2 x 1-year options. The estimated contract value is based on 7 years.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
6 Feb 2026 Preliminary market engagement (UK2) Procurement Act 2023 010748-2026
20 Apr 2026 Preliminary market engagement (UK2) Procurement Act 2023 035465-2026

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.